Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Spyre Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
107
+5 vs. Q1 2024
Shares held
50.4M
+18.0M (+55.7%) vs. Q1 2024
Total value
$1.18B
−$28.4M (−2.3%) vs. Q1 2024
New holders
29
47 more added
Sold out
24
17 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 107 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ2 2024: $1.18B
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding SYRE in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock Inc.2,403,441$56.5M0.00%+1,846,750+331.7%Added
Braidwell LP2,514,538$59.1M1.85%+1,999,538+388.3%Added
VR Adviser, LLC2,685,448$63.1M4.02%+513,666+23.7%Added
Perceptive Advisors LLC3,031,018$71.3M1.72%+474,339+18.6%Added
RTW Investments, LP3,258,360$76.6M1.19%+1,025,600+45.9%Added
Fairmount Funds Management LLC4,018,101$94.5M10.67%+3,639,680+961.8%Added
FMR LLC7,507,983$176.5M0.01%+924,228+14.0%Added
Fan Yu0$00.00%−737,000−100.0%Sold out
Millennium Management LLC0$00.00%−319,563−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−250,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−161,921−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−101,503−100.0%Sold out
Nicholas Investment Partners, LP0$00.00%−89,962−100.0%Sold out
HRT Financial LP0$00.00%−78,996−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−64,400−100.0%Sold out
Renaissance Technologies LLC0$00.00%−49,468−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−49,303−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−31,800−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−24,472−100.0%Sold out
Fred Alger Management, LLC0$00.00%−18,158−100.0%Sold out
Engineers Gate Manager LP0$00.00%−15,653−100.0%Sold out
Scientech Research LLC0$00.00%−13,143−100.0%Sold out
Legato Capital Management LLC0$00.00%−11,458−100.0%Sold out
LMR Partners LLP0$00.00%−11,093−100.0%Sold out
Polymer Capital Management (HK) LTD0$00.00%−10,520−100.0%Sold out
Squarepoint Ops LLC0$00.00%−8,161−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−8,075−100.0%Sold out
Chartwell Investment Partners, LLC0$00.00%−6,835−100.0%Sold out
Arizona State Retirement System0$00.00%−5,445−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−22−100.0%Sold out
Macquarie Group Ltd0$00.00%−2,523−100.0%Sold out
Credit Suisse AG––––Not filed